NeuroLicensing 2017-18 is our completely revised/updated review of current trends in deal parameters, and focuses on the major and midsize companies who are involved in CNS licensing. Opportunities and licensing agendas/performance are candidly appraised. A practical and affordable resource for licensing efforts on both sides of the transaction, both potential licensors and licensees. 106 pages. Released 9/18/17.      US$3750


To download Information/TOC for NL 2017-18